Analysis of Itamar Medical manpower and management performance can provide insight into Itamar Medical stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Itamar Medical future performance. Please also check Risk vs Return Analysis.
Itamar Medical Management EffectivenessThe company has return on total asset (ROA) of (11.05) % which means that it has lost $11.05 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (75.4) % meaning that it generated substantial loss on money invested by shareholders.
Itamar Medical Workforce Comparison
Itamar Medical Ltd is rated second overall in number of employees category among related companies. The total workforce of Medical Devices industry is currently estimated at about 241. Itamar Medical holds roughly 16.0 in number of employees claiming about 7% of all equities under Medical Devices industry.
Itamar Medical Profit MarginsThe company has Profit Margin (PM) of (15.8) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (14.71) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.15.
Itamar Medical Stakeholders
|Gilad Glick CEO and Pres|
|Martin Gerstel Co-Chairman, Bus. Advisor, Member of Executive Committee and Member of Investment Committee|
|Giora Yaron Co-Chairman, Bus. Advisor and Member of Executive Committee|
|Ira Prigat VP and President of Itamar Medical Japan|
|Arnon Tuval Vice President of Operations - Itamar Medical Inc.|
|Joseph Tenne Vice President - Finance|
|Shlomo Ayanot Vice President of Operations & Engineering|
|Christopher Hallett Vice President of Sales - Itamar Medical Inc. - North American|
|Shay Basson Vice President - Finance|
|Efrat Litman Vice President - Research & Development|
|Shaul Sharoni CFO and Sr. VP|
|Jacob Sheffy CTO and Executive VP|
|Miri Katz External Director|
|Jonathan Kolber Director|
|Christopher Cleary Director|
|Maya TalPachter Director, Global Marketing|
|Shmuel Blumenfeld Director|
|Zipora OzerArmon External Director|
|Steven Ruchefsky Director|
|Gary Ellis Director|
|Sami Totah Director|
|Yaffa Sieradzki External Director|
|Yair Orgler External Director|
|Dafna Katz VP of Global Marketing|
|Eldad Singer VP of Sales Research|
|Daphna Triwaks Head of PR|
|Shahar Cohen Controller|
Itamar Medical employes about 16 people. The company is managed by 27 executives with total tenure of roughly 168 years, averanging almost 6.0 years of service per executive having 0.0 employee per reported executive.
|Revenue Per Employee||1.5 M|
|Revenue Per Executive||874.8 K|
|Net Loss Per Employee||233.1 K|
|Net Loss Per Executive||138.1 K|
|Working Capital Per Employee||1.8 M|
|Working Capital Per Executive||1 M|